NCT04511338View on ClinicalTrials.gov

Feasibility Study for Heparin-free Hemodialysis With the Dialyzer With Endexo™

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 2, 2020

Primary Completion Date

May 21, 2021

Study Completion Date

June 16, 2021

Conditions
Chronic Kidney DiseasesPatient Requiring Heparin Free Dialysis Treatments
Interventions
DEVICE

Dialyzer with Endexo

"Sequence AB:~Period 1 Circuit A (Five Visits: 1,2,3,4,5) Period 2 Circuit B (Five Visits: 9,10,11,12,13)~Sequence BA:~Period 1 Circuit B (Five Visits: 1,2,3,4,5) Period 2 Circuit A (Five Visits: 9,10,11,12,13)"

Trial Locations (2)

28560

Fresenius Kidney Care Craven County Dialysis Center, New Bern

New Bern Dialysis Unit, New Bern

All Listed Sponsors
lead

Fresenius Medical Care North America

INDUSTRY

NCT04511338 - Feasibility Study for Heparin-free Hemodialysis With the Dialyzer With Endexo™ | Biotech Hunter | Biotech Hunter